VD
Vamil Divan Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
37
Avg Return
Past Year
Past Year
21%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
91.3%
Neutral
8.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $23 |
43%
upside
| 3 | +33% |
0
%
| 11 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $140 |
22%
upside
| 2 | +27% |
0
%
| 6 Feb ‘26 4 months ago |
|
|
|
Neutral
Maintained
| $347 |
1%
downside
| 2 | – |
–
| 6 Feb ‘26 4 months ago |
|
|
|
Buy
Maintained
| $240 |
2%
upside
| 5 | +12% |
0
%
| 23 Jan ‘26 4 months ago |
|
|
|
Buy
Maintained
| $124 |
51%
upside
| 5 | +3.8% |
0
%
| 16 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $221 |
127%
upside
| 2 | +4.5% |
0
%
| 18 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $35 |
35%
upside
| 2 | +1.3% |
0
%
| 24 Nov ‘25 6 months ago |
|
|
|
Buy
Maintained
| $8 |
133%
upside
| 1 | +67% |
0
%
| 18 Nov ‘25 7 months ago |
|
|
|
Buy
Maintained
| $3 |
27%
downside
| 1 | +19% |
0
%
| 28 Oct ‘25 7 months ago |
|
|
|
Buy
Maintained
| $242 |
9%
upside
| 4 | +7.1% |
0
%
| 20 Oct ‘25 7 months ago |
|
|
|
Buy
Maintained
| $11 |
106%
upside
| 2 | +67% |
0
%
| 9 Sep ‘25 9 months ago |
|
|
|
Buy
Maintained
| $13 |
141%
upside
| 2 | +27% |
0
%
| 8 Sep ‘25 9 months ago |
|
|
|
Buy
Maintained
| $39 |
67%
upside
| 2 | +68% |
0
%
| 8 Sep ‘25 9 months ago |
|
|
|
Buy
Maintained
| $7 |
319%
upside
| 1 | -52% |
0
%
| 14 Jul ‘25 11 months ago |
|